<table border="single" id="id_05f7d600-1a0b-44bf-974c-417c4dda8e75" width="412" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 18: The Effect of Quetiapine on the Pharmacokinetics of Other Drugs</caption>
<col span="1" width="23.2%"></col>
<col span="1" width="23.2%"></col>
<col span="1" width="17.5%"></col>
<col span="1" width="36.3%"></col>
<tbody>
<tr>
<td></td>
<td>
<content stylecode="bold">Dose Schedules</content>
</td>
<td>
<paragraph>
<content stylecode="bold">Effect on Other</content>
</paragraph>
<paragraph>
<content stylecode="bold">Drugs</content>
</paragraph>
<content stylecode="bold">Pharmacokinetics</content>
</td>
</tr>
<tr>
<td>
<paragraph>
<content stylecode="bold">Coadministered</content>
</paragraph>
<content stylecode="bold">Drug</content>
</td>
<td>
<paragraph>
<content stylecode="bold">Coadministered</content>
</paragraph>
<content stylecode="bold">Drug</content>
</td>
<td>
<content stylecode="bold">Quetiapine</content>
</td>
</tr>
<tr>
<td>Lorazepam</td>
<td>2 mg, single dose</td>
<td>
<paragraph>250 mg three</paragraph>times daily</td>
<td>Oral clearance of lorazepam reduced by 20%</td>
</tr>
<tr>
<td>Divalproex</td>
<td>500 mg twice daily</td>
<td>
<paragraph>150 mg</paragraph>twice daily</td>
<td>C<sub>max</sub> and AUC of free valproic acid at steady-state was decreased by 10 to 12%</td>
</tr>
<tr>
<td>Lithium</td>
<td>
<paragraph>Up to 2400 mg/day given in twice daily</paragraph>doses</td>
<td>
<paragraph>250 mg three</paragraph>times daily</td>
<td>No effect on steady state pharmacokinetics of lithium</td>
</tr>
<tr>
<td>Antipyrine</td>
<td>1 g, single dose</td>
<td>
<paragraph>250 mg three</paragraph>times daily</td>
<td>
<paragraph>No effect on clearance of</paragraph>antipyrine or urinary recovery of its metabolites</td>
</tr>
</tbody>
</table>